PUNE, India, May 1, 2017 /PRNewswire/ --
One trend in the global therapeutic drug monitoring market is advent of POC tests. The emergence of POC tests for therapeutic drug monitoring will likely change the market dynamics. The financial costs associated with instrumental operation and maintenance, and the time needed for the preparation and analysis of samples for processing the results, affects the application of therapeutic drug monitoring in medical practices.
Browse 39 Exhibits, 5 Major Company Profiles, spread across 70 pages available at http://www.reportsnreports.com/reports/966158-global-therapeutic-drug-monitoring-market-2017-2021.html.
According to the therapeutic drug monitoring market report, one driver in the market is increasing demand for personalized medicine. The increasing need for personalized medicine has driven the demand for therapeutic drug monitoring. It is important to get the drug right in content and in quantity (dosage) to offer better care to individuals; however, in many cases, it is given manually by the physicians. This could affect the patient compliance. Therefore, therapeutic drug monitoring is required to find out the correct content and dosage specific to the individual.
The following companies as the key players in the global therapeutic drug monitoring market: Beckman Coulter, Bio-Rad Laboratories, F. Hoffmann-La Roche, Siemens Healthcare and Thermo Fisher Scientific. Other prominent vendors in the market are: Adaptive Biotechnologies, AESKU. Diagnostics, Alere, bioMérieu, Bio-Techne, BÜHLMANN Laboratories, DiaSorin, Euro Diagnostica, Exagen Diagnostics, IDEXX Laboratories, InSource Diagnostics, Merck Millipore, Miraca Life Sciences, Myriad Genetics, Phadia, Quest Diagnostics, SEKISUI MEDICAL, SQI Diagnostics, Tecan, and Theradiag. Order a copy of Global Therapeutic Drug Monitoring Market 2017-2021 research report at http://www.reportsnreports.com/purchase.aspx?name=966158.
Global Therapeutic Drug Monitoring Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the present scenario and the growth prospects of the global therapeutic drug monitoring market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
Global Intravenous Iron Drugs Market 2017-2021 - The analysts forecast global IV iron drugs market to grow at a CAGR of 10.46% during the period 2017-2021. Iron deficiency can affect the production of hemoglobin and cause anemia. This condition is known as iron deficiency anemia.
Global Dyslipidemia Drugs Market 2017-2021 - Dyslipidaemia is the imbalance in the lipid level in the bloodstream. It is characterized by high levels of total cholesterol and low-density lipoprotein cholesterol (LDL-C) in the blood. High cholesterol levels can cause cardiovascular diseases (CVD) such as stroke and atherosclerosis.
Global Lifestyle Drugs Market 2017-2021 - Lifestyle disease is associated with the way an individual or group of people live. Some of the lifestyle diseases include depression, sexual dysfunction, anti-aging, baldness, and obesity.
Explore more reports on Medical Devices at http://www.reportsnreports.com/market-research/medical-devices/.
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
2nd Floor, Metropole Building,
Next to Inox Theatre,
Bund Garden Road, Pune - 411013.
Connect with Us: